Literature DB >> 12113112

Issues in the epidemiology of melanoma.

S Oliveria1, S Dusza, M Berwick.   

Abstract

Cutaneous melanoma is a significant health problem throughout the developing world. Primary and secondary prevention are discussed. The wavelengths of the ultraviolet radiation spectrum and their association with melanoma are discussed. Although excessive sun exposure during childhood is a critical risk factor, excessive sun exposure during adult years is also important. The major risk factors for melanoma--numerous or atypical moles and a sun-sensitive phenotype--are genetic. Their interaction with sun exposure is currently being examined, as well as the interaction of other genetic factors, such as alterations in the melanocortin receptor and the familial melanoma gene, INK4A. Secondary prevention strategies include self-examination and physician examination. New technologies are being developed to supplement visual examination of suspected lesions. These technologies are discussed in detail and include digital photography, digital dermoscopy, confocal scanning laser microscopy and automated diagnosis systems.

Entities:  

Mesh:

Year:  2001        PMID: 12113112     DOI: 10.1586/14737140.1.3.453

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  11 in total

1.  Rb-Raf-1 interaction disruptor RRD-251 induces apoptosis in metastatic melanoma cells and synergizes with dacarbazine.

Authors:  Sandeep Singh; Rebecca Davis; Vignesh Alamanda; Roberta Pireddu; Daniel Pernazza; Said Sebti; Nicholas Lawrence; Srikumar Chellappan
Journal:  Mol Cancer Ther       Date:  2010-12-07       Impact factor: 6.261

Review 2.  Role of nuclear factor-kappa B in melanoma.

Authors:  Katayoun I Amiri; Ann Richmond
Journal:  Cancer Metastasis Rev       Date:  2005-06       Impact factor: 9.264

3.  Melanocyte transformation associated with substrate adhesion impediment.

Authors:  Sueli M Oba-Shinjo; Mariangela Correa; Tatiana I Ricca; Fernanda Molognoni; Maria A Pinhal; Izabel A Neves; Sueli K Marie; Lúcia O Sampaio; Helena B Nader; Roger Chammas; Miriam G Jasiulionis
Journal:  Neoplasia       Date:  2006-03       Impact factor: 5.715

4.  Systemic and local injections of lupeol inhibit tumor growth in a melanoma-bearing mouse model.

Authors:  Makiko Nitta; Kazuo Azuma; Keishi Hata; Saori Takahashi; Kikumi Ogiwara; Takeshi Tsuka; Tomohiro Imagawa; Inoru Yokoe; Tomohiro Osaki; Saburo Minami; Yoshiharu Okamoto
Journal:  Biomed Rep       Date:  2013-05-28

5.  The contribution of electron paramagnetic resonance to melanoma research.

Authors:  Quentin Godechal; Bernard Gallez
Journal:  J Skin Cancer       Date:  2011-09-20

Review 6.  NF-κB as potential target in the treatment of melanoma.

Authors:  Gabriele Madonna; Claudio Dansky Ullman; Giusy Gentilcore; Giuseppe Palmieri; Paolo Antonio Ascierto
Journal:  J Transl Med       Date:  2012-03-20       Impact factor: 5.531

7.  Differentiation-inducing and anti-proliferative activities of lupeol on canine melanoma cells.

Authors:  Kikumi Ogihara; Yuko Naya; Yoshiharu Okamoto; Keishi Hata
Journal:  Springerplus       Date:  2014-10-25

Review 8.  Main roads to melanoma.

Authors:  Giuseppe Palmieri; Mariaelena Capone; Maria Libera Ascierto; Giusy Gentilcore; David F Stroncek; Milena Casula; Maria Cristina Sini; Marco Palla; Nicola Mozzillo; Paolo A Ascierto
Journal:  J Transl Med       Date:  2009-10-14       Impact factor: 5.531

9.  Melanoma cell migration is upregulated by tumour necrosis factor-alpha and suppressed by alpha-melanocyte-stimulating hormone.

Authors:  N Zhu; R Lalla; P Eves; T L H Brown; A King; E H Kemp; J W Haycock; S MacNeil
Journal:  Br J Cancer       Date:  2004-04-05       Impact factor: 7.640

10.  Management of melanoma families.

Authors:  Wilma Bergman; Nelleke A Gruis
Journal:  Cancers (Basel)       Date:  2010-04-16       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.